K, J., W, A., A, M., I, S., B, D., G, R., . . . Z, B. (2025). Anti-inflammatory 25(OH)D3, a natural steroid hormone, may complement all-trans retinoic acid therapy for differentiation syndrome in acute promyelocytic leukemia. Cell death & disease, 16(1), 787. https://doi.org/10.1038/s41419-025-08109-7
Chicago Style (17th ed.) CitationK, Jambrovics, Al-Hadban W, Mázló-Türk A, Szatmari I, Dobó B, Reményi G, Jóna Á, Koncz G, and Balajthy Z. "Anti-inflammatory 25(OH)D3, a Natural Steroid Hormone, May Complement All-trans Retinoic Acid Therapy for Differentiation Syndrome in Acute Promyelocytic Leukemia." Cell Death & Disease 16, no. 1 (2025): 787. https://doi.org/10.1038/s41419-025-08109-7.
MLA (9th ed.) CitationK, Jambrovics, et al. "Anti-inflammatory 25(OH)D3, a Natural Steroid Hormone, May Complement All-trans Retinoic Acid Therapy for Differentiation Syndrome in Acute Promyelocytic Leukemia." Cell Death & Disease, vol. 16, no. 1, 2025, p. 787, https://doi.org/10.1038/s41419-025-08109-7.